Literature DB >> 9403558

Mannose 6-phosphate receptor-mediated internalization and activation of prorenin by cardiac cells.

C A van Kesteren1, A H Danser, F H Derkx, D H Dekkers, J M Lamers, P R Saxena, M A Schalekamp.   

Abstract

The binding and internalization of recombinant human renin and prorenin (2500 microU/mL) and the activation of prorenin were studied in neonatal rat cardiac myocytes and fibroblasts cultured in a chemically defined medium. Surface-bound and internalized enzymes were distinguished by the addition of mannose 6-phosphate to the medium, by incubating the cells both at 37 degrees C and 4 degrees C, and by the acid-wash method. Mannose 6-phosphate inhibited the binding of renin and prorenin to the myocyte cell surface in a dose-dependent manner. At 37 degrees C, after incubation at 4 degrees C for 2 hours, 60% to 70% of cell surface-bound renin or prorenin was internalized within 5 minutes. Intracellular prorenin was activated, but extracellular prorenin was not. The half-time of activation at 37 degrees C was 25 minutes. Ammonium chloride and monensin, which interfere with the normal trafficking and recycling of internalized receptors and ligands, inhibited the activation of prorenin. Results obtained with cardiac fibroblasts were comparable to those in the myocytes. This study is the first to show experimental evidence for the internalization and activation of prorenin in extrarenal cells by a mannose 6-phosphate receptor-dependent process. Our findings may have physiological significance in light of recent experimental data indicating that angiotensin I and II are produced at cardiac and other extrarenal tissue sites by the action of renal renin and that intracellular angiotensin II can elicit important physiological responses.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9403558     DOI: 10.1161/01.hyp.30.6.1389

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  19 in total

Review 1.  Intracardiac intracellular angiotensin system in diabetes.

Authors:  Rajesh Kumar; Qian Chen Yong; Candice M Thomas; Kenneth M Baker
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-12-14       Impact factor: 3.619

2.  Renin and cardiovascular disease: Worn-out path, or new direction.

Authors:  Gaurav Alreja; Jacob Joseph
Journal:  World J Cardiol       Date:  2011-03-26

Review 3.  The (pro)renin receptor and its interaction partners.

Authors:  Jörg Peters
Journal:  Pflugers Arch       Date:  2017-06-15       Impact factor: 3.657

Review 4.  Targeting cardiac mast cells: pharmacological modulation of the local renin-angiotensin system.

Authors:  Alicia C Reid; Jacqueline A Brazin; Christopher Morrey; Randi B Silver; Roberto Levi
Journal:  Curr Pharm Des       Date:  2011-11       Impact factor: 3.116

Review 5.  Is angiotensin II made inside or outside of the cell?

Authors:  Wenxia Chai; A H Jan Danser
Journal:  Curr Hypertens Rep       Date:  2005-04       Impact factor: 5.369

6.  Inhibition of diabetic nephropathy by a decoy peptide corresponding to the "handle" region for nonproteolytic activation of prorenin.

Authors:  Atsuhiro Ichihara; Matsuhiko Hayashi; Yuki Kaneshiro; Fumiaki Suzuki; Tsutomu Nakagawa; Yuko Tada; Yukako Koura; Akira Nishiyama; Hirokazu Okada; M Nasir Uddin; A H M Nurun Nabi; Yuichi Ishida; Tadashi Inagami; Takao Saruta
Journal:  J Clin Invest       Date:  2004-10       Impact factor: 14.808

Review 7.  Strategies for carbohydrate recognition by the mannose 6-phosphate receptors.

Authors:  Nancy M Dahms; Linda J Olson; Jung-Ja P Kim
Journal:  Glycobiology       Date:  2008-07-11       Impact factor: 4.313

8.  The putative (pro)renin receptor blocker HRP fails to prevent (pro)renin signaling.

Authors:  Sandra Feldt; Ulrike Maschke; Ralf Dechend; Friedrich C Luft; Dominik N Muller
Journal:  J Am Soc Nephrol       Date:  2008-01-30       Impact factor: 10.121

Review 9.  Direct renin inhibition: clinical pharmacology.

Authors:  Michel Azizi
Journal:  J Mol Med (Berl)       Date:  2008-03-27       Impact factor: 4.599

Review 10.  Mannose 6-phosphate receptor targeting and its applications in human diseases.

Authors:  M Gary-Bobo; P Nirdé; A Jeanjean; A Morère; M Garcia
Journal:  Curr Med Chem       Date:  2007       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.